Oprimed is leading clinical trial innovation with OPTIVIS, the world’s only AI-based digital twin platform capable of simulating East Asian virtual patients.

Oprimed Co., Ltd. has developed OPTIVIS, Korea’s first AI-based human digital twin platform, revolutionizing clinical trial design and outcome prediction.
OPTIVIS creates virtual patients statistically similar to real ones, enabling reduced enrollment and early identification of drug responders.
Uniquely, it is the only platform globally capable of simulating East Asian patients, offering a competitive edge in international trials.
Digital twin technology is gaining traction as a future-oriented alternative to animal testing, with support from regulators like the FDA and EMA.
Oprimed is emerging as a leading digital twin solution provider in Asia, driving innovation in the global digital healthcare market.

View article

View all

2024. 8. 13.

Female Entrepreneurs Gather at the 25th Women's Startup Competition

Suji Hong, CEO of Oprimed Co., Ltd., received the Chairperson’s Award from the Korea Center for Women in Business at the 25th Women’s Startup Competition in recognition of her company’s technological excellence in the field of AI and bio-health.

2024. 8. 13.

Female Entrepreneurs Gather at the 25th Women's Startup Competition

2024. 8. 13.

Female Entrepreneurs Gather at the 25th Women's Startup Competition

2024. 11. 18.

Hanging Mice and Pulling Tails — Is the Era of Animal Testing Coming to an End?

Suji Hong, CEO of Oprimed, presented an AI-driven preclinical testing method that leverages digital twin technology to predict drug outcomes and replicate animal data, offering an alternative to animal testing and potentially reducing the number of laboratory animals by more than half.

2024. 11. 18.

Hanging Mice and Pulling Tails — Is the Era of Animal Testing Coming to an End?

2024. 11. 18.

Hanging Mice and Pulling Tails — Is the Era of Animal Testing Coming to an End?

2024. 12. 6.

Oprimed Selected for the 2024 TIPS Program

Oprimed Co., Ltd., a digital twin clinical simulation startup, was selected for the Deep Tech TIPS program by the Korean Ministry of SMEs and Startups, receiving up to KRW 1.7 billion to enhance its OPTIVIS technology and accelerate global expansion.